MaaT Pharma SA (EPA:MAAT)

France · Delayed Price · Currency is EUR

7.38

-0.30 (-3.91%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Oncology Research and Development	3.22M	2.23M	1.43M	972.00K		89.30K
Oncology Research and Development Growth	44.34%	55.80%	47.12%	-		-89.99%
Total	3.22M	2.23M	1.43M	972.00K		89.30K
Total Growth	44.34%	55.80%	47.12%	-		-89.99%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
France	3.22M	2.23M	1.43M	972.00K		89.30K
France Growth	44.34%	55.80%	47.12%	-		-89.99%
Total	3.22M	2.23M	1.43M	972.00K		89.30K
Total Growth	44.34%	55.80%	47.12%	-		-89.99%

Source: S&P Global Market Intelligence.